{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:26:36Z","timestamp":1794864396910,"version":"4.9.1"},"reference-count":85,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Pyrazole is a bioactive heterocyclic congener with numerous biological and\npharmacological functionalities. Due to their multiple prospective applications, developing innovative\nand novel pyrazoles and analogs, revealing revolutionary methods for synthesizing this nucleus,\ninvestigating diverse potencies of that heterocycle, and exploring possible pyrazole applications are\nbecoming increasingly relevant.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>Pyrazole scaffolds have been proven successful as antimicrobial, anticancer, and antimalarial\ntherapeutics against multiple targets like DNA gyrase, topoisomerase IV, Hsp90, and several\nkinase enzymes. For this variability in the biotic zone, their moiety has gained the attention of many\nscientists interested in researching chemical and pharmacological profiles.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The review covers pyrazole scaffolds with a variety of biological functions and attempts to\nconnect the structure-activity relationship. Multiple pyrazole analogs have been produced as lead\ncompounds, and their activities have been evaluated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The combination of pyrazole with other pharmacophores in a molecule might lead to\nnovel potent therapeutic medicines, which could aid in the development of potent lead compounds.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406418666220303150640","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T06:46:47Z","timestamp":1646376407000},"page":"1044-1059","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A Molecular Insight into Pyrazole Congeners as Antimicrobial, Anticancer,\nand Antimalarial Agents"],"prefix":"10.2174","volume":"18","author":[{"given":"Dipanjan","family":"Karati","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University),\nErandwane, Pune 411038, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakasaheb Ramoo","family":"Mahadik","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University),\nErandwane, Pune 411038, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Center of Innovation and Translational Research, Poona College of\nPharmacy, Bhartiya Vidyapeeth, Pune 411038, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3418-4325","authenticated-orcid":true,"given":"Dileep","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University),\nErandwane, Pune 411038, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1021\/cr300176g","volume":"113","author":"Eftekhari-Sis B.","year":"2013","unstructured":"Eftekhari-Sis B.; Zirak M.; Akbari A.; Arylglyoxals in synthesis of heterocyclic compounds. Chem Rev 2013,113(5),2958-3043","journal-title":"Chem Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1039\/C6NJ03181A","volume":"41","author":"Ansari A.","year":"2017","unstructured":"Ansari A.; Ali A.; Asif M.; Biologically active pyrazole derivatives. New J Chem 2017,41,16","journal-title":"New J Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.3390\/molecules24213839","volume":"24","author":"Jampilek J.","year":"2019","unstructured":"Jampilek J.; Heterocycles in medicinal chemistry. Molecules 2019,24(21),3839","journal-title":"Molecules"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/molecules25081909","volume":"25","author":"Kerru N.","year":"2020","unstructured":"Kerru N.; Gummidi L.; Maddila S.; Gangu K.K.; Jonnalagadda S.B.; A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules 2020,25(8),1909","journal-title":"Molecules"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1021\/jo051878h","volume":"71","author":"Ju Y.","year":"2006","unstructured":"Ju Y.; Varma R.S.; Aqueous N-heterocyclization of primary amines and hydrazines with dihalides: Microwave-assisted syntheses of N-azacycloalkanes, isoindole, pyrazole, pyrazolidine, and phthalazine derivatives. J Org Chem 2006,71(1),135-141","journal-title":"J Org Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.3390\/molecules26113103","volume":"26","author":"El Azab I.H.","year":"2021","unstructured":"El Azab I.H.; Bakr R.B.; Elkanzi N.A.A.; Facile one-pot multicomponent synthesis of pyrazolo-thiazole substituted pyridines with poten-tial anti-proliferative activity: Synthesis, in vitro and in silico studies. Molecules 2021,26(11),3103","journal-title":"Molecules"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1021\/jm00036a001","volume":"37","author":"Gordon E.M.","year":"1994","unstructured":"Gordon E.M.; Barrett R.W.; Dower W.J.; Fodor S.P.A.; Gordon M.A.; Applications of combinatorial technologies to drug discovery. 1. background and peptide combinatorial libraries. J Med Chem 1994,37(9),1385","journal-title":"J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.22159\/ajpcr.2017.v10i12.22065","volume":"10","author":"Ardiansah B.","year":"2017","unstructured":"Ardiansah B.; Recent Reports on pyrazole-based bioactive compounds as candidate for anticancer agents. Asian J Pharm Clin Res 2017,10(12),45","journal-title":"Asian J Pharm Clin Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1039\/c2gc16425f","volume":"14","author":"Srivastava M.","year":"2012","unstructured":"Srivastava M.; Singh J.; Singh S.B.; Tiwari K.; Pathak K.V.; Singh J.; Synthesis of novel fused heterocycle-oxa-aza-phenanthrene and anthracene derivatives via sequential one-pot synthesis in aqueous micellar system. Green Chem 2012,14(4),901","journal-title":"Green Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.tetlet.2016.06.019","volume":"57","author":"Pai G.","year":"2016","unstructured":"Pai G.; Chattopadhyay A.P.; N-arylation of nitrogen containing heterocycles with aryl halides using copper nanoparticle catalytic system. Tetrahedron Lett 2016,57(29),3140","journal-title":"Tetrahedron Lett"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.bmcl.2004.03.013","volume":"14","author":"Schenone S.","year":"2004","unstructured":"Schenone S.; Bruno O.; Ranise A.; Bondavalli F.; Brullo C.; Fossa P.; Mosti L.; Menozzi G.; Carraro F.; Naldini A.; Bernini C.; Manetti F.; Botta M.; New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation. Bioorg Med Chem Lett 2004,14(10),2511-2517","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejmech.2003.11.012","volume":"39","author":"Daidone G.","year":"2004","unstructured":"Daidone G.; Raffa D.; Maggio B.; Valeria Raimondi M.; Plescia F.; Schillaci D.; Synthesis and antiproliferative activity of tri-azenoindazoles and triazenopyrazoles: A comparative study. Eur J Med Chem 2004,39(3),219-224","journal-title":"Eur J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0968-0896(02)00533-3","volume":"11","author":"Baraldi P.G.","year":"2003","unstructured":"Baraldi P.G.; Beria I.; Cozzi P.; Bianchi N.; Gambari R.; Romagnoli R.; Synthesis and growth inhibition activity of alpha-bromoacrylic heterocyclic and benzoheterocyclic derivatives of distamycin A modified on the amidino moiety. Bioorg Med Chem 2003,11(6),965-975","journal-title":"Bioorg Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2174\/1389557511009011014","volume":"10","author":"Bekhit A.A.","year":"2010","unstructured":"Bekhit A.A.; Hymete A.; El-Din A.; Bekhit A.; Damtew A.; Aboul-Enein H.Y.; Pyrazoles as promising scaffold for the synthesis of anti-inflammatory and\/or antimicrobial agent: A review. Mini Rev Med Chem 2010,10(11),1014-1033","journal-title":"Mini Rev Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"S1590","DOI":"10.1016\/j.arabjc.2013.05.029","volume":"10","author":"Bhatt H.B.","year":"2017","unstructured":"Bhatt H.B.; Sharma S.; Synthesis and antimicrobial activity of pyrazole nucleus containing 2-thioxothiazolidin-4-one derivatives. Arab J Chem 2017,10,S1590-S1596","journal-title":"Arab J Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3109\/14756366.2012.720572","volume":"28","author":"Sharma P.C.","year":"2013","unstructured":"Sharma P.C.; Sinhmar A.; Sharma A.; Rajak H.; Pathak D.P.; Medicinal significance of benzothiazole scaffold: An insight view. J Enzyme Inhib Med Chem 2013,28(2),240-266","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/1573407214666180827094725","volume":"15","author":"Sharma D.","year":"2019","unstructured":"Sharma D.; Bansal K.K.; Sharma A.; Pathak M.; Sharma P.; A brief literature and review of patents on thiazole related derivatives. Curr Bioact Compd 2019,15(3),304-315","journal-title":"Curr Bioact Compd"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/j.bmcl.2007.03.003","volume":"17","author":"Gomez L.","year":"2007","unstructured":"Gomez L.; Hack M.D.; Wu J.; Wiener J.J.M.; Venkatesan H.; Santill\u00e1n A.; Pippel D.J.; Mani N.; Morrow B.J.; Motley S.T.; Shaw K.J.; Wolin R.; Grice C.A.; Jones T.K.; Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: Synthesis and preliminary SAR analysis. Bioorg Med Chem Lett 2007,17(10),2723-2727","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.coph.2008.04.009","volume":"8","author":"Bradbury B.J.","year":"2008","unstructured":"Bradbury B.J.; Pucci M.J.; Recent advances in bacterial topoisomerase inhibitors. Curr Opin Pharmacol 2008,8(5),574-581","journal-title":"Curr Opin Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.ejmech.2011.03.045","volume":"46","author":"Bondock S.","year":"2011","unstructured":"Bondock S.; Khalifa W.; Fadda A.A.; Synthesis and antimicrobial activity of some new 4-hetarylpyrazole and furo[2,3-c]pyrazole deriva-tives. Eur J Med Chem 2011,46(6),2555-2561","journal-title":"Eur J Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.ejmech.2007.08.002","volume":"43","author":"Rai N.S.","year":"2008","unstructured":"Rai N.S.; Kalluraya B.; Lingappa B.; Shenoy S.; Puranic V.G.; Convenient access to 1,3,4-trisubstituted pyrazoles carrying 5-nitrothiophene moiety via 1,3-dipolar cycloaddition of sydnones with acetylenic ketones and their antimicrobial evaluation. Eur J Med Chem 2008,43(8),1715-1720","journal-title":"Eur J Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.ejmech.2009.12.020","volume":"45","author":"Gouda M.A.","year":"2010","unstructured":"Gouda M.A.; Berghot M.A.; Abd El-Ghani G.E.; Khalil A.M.; Synthesis and antimicrobial activities of some new thiazole and pyrazole derivatives based on 4,5,6,7-tetrahydrobenzothiophene moiety. Eur J Med Chem 2010,45(4),1338-1345","journal-title":"Eur J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1016\/j.bmcl.2010.07.019","volume":"20","author":"Gadakh A.V.","year":"2010","unstructured":"Gadakh A.V.; Pandit C.; Rindhe S.S.; Karale B.K.; Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles. Bioorg Med Chem Lett 2010,20(18),5572-5576","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.ejmech.2008.09.029","volume":"44","author":"Abdel-Wahab B.F.","year":"2009","unstructured":"Abdel-Wahab B.F.; Abdel-Aziz H.A.; Ahmed E.M.; Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles. Eur J Med Chem 2009,44(6),2632-2635","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jsps.2011.01.005","volume":"19","author":"Thumar N.J.","year":"2011","unstructured":"Thumar N.J.; Patel M.P.; Synthesis, characterization, and antimicrobial evaluation of carbostyril derivatives of 1H-pyrazole. Saudi Pharm J 2011,19(2),75-83","journal-title":"Saudi Pharm J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1016\/j.bmcl.2011.03.101","volume":"21","author":"Boschi D.","year":"2011","unstructured":"Boschi D.; Guglielmo S.; Aiello S.; Morace G.; Borghi E.; Fruttero R.; Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivatives. Bioorg Med Chem Lett 2011,21(11),3431-3434","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1016\/j.ejmech.2011.05.005","volume":"46","author":"Vijesh A.M.","year":"2011","unstructured":"Vijesh A.M.; Isloor A.M.; Telkar S.; Peethambar S.K.; Rai S.; Isloor N.; Synthesis, characterization and antimicrobial studies of some new pyrazole incorporated imidazole derivatives. Saudi Pharm J 2011,46(8),3531-3536","journal-title":"Saudi Pharm J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1007\/s00044-011-9796-9","volume":"21","author":"Chandrakantha B.","year":"2012","unstructured":"Chandrakantha B.; Isloor A.M.; Shetty P.; Isloor S.; Malladi S.; Fun H.K.; Synthesis, characterization and antimicrobial activity of nov-el ethyl 1-(N-substituted)-5-phenyl-1H-pyrazole-4-carboxylate derivatives. Med Chem Res 2012,21,2702-2708","journal-title":"Med Chem Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.ejmech.2011.01.060","volume":"46","author":"Sharma P.K.","year":"2011","unstructured":"Sharma P.K.; Chandak N.; Kumar P.; Sharma C.; Aneja K.R.; Synthesis and biological evaluation of some 4-functionalized-pyrazoles as antimicrobial agents. Eur J Med Chem 2011,46(4),1425-1432","journal-title":"Eur J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2191-2858-1-8","volume":"1","author":"Kanagarajan V.","year":"2011","unstructured":"Kanagarajan V.; Ezhilarasi M.R.; Gopalakrishnan M.; In vitro microbiological evaluation of 1,1'-(5,5'-(1,4-phenylene)bis(3-aryl-1H-pyrazole-5,1-(4H,5H)-diyl))diethanones, novel bisacetylated pyrazoles. Org Med Chem Lett 2011,1(1),8","journal-title":"Org Med Chem Lett"},{"key":"ref=31","unstructured":"National Cancer Institute. 2021. Available from:"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1871520621666210811105344","volume":"21","author":"Karati D.","year":"2021","unstructured":"Karati D.; Mahadik K.R.; Trivedi P.; Kumar D.; Alkylating agents, the road less traversed, changing anticancer therapy. Anticancer Agents Med Chem 2021,21,1-7","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"Siegel R.","year":"2014","unstructured":"Siegel R.; Ma J.; Zou Z.; Jemal A.; Cancer statistics, 2014. CA Cancer J Clin 2014,64(1),9-29","journal-title":"CA Cancer J Clin"},{"key":"ref=34","unstructured":"World Health Organization. Cancer, Fact sheet N\u00b0297 Available from:  (Accessed on: September 12, 2018)."},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"102944","DOI":"10.1016\/j.bioorg.2019.102944","volume":"88","author":"Elmetwally S.A.","year":"2019","unstructured":"Elmetwally S.A.; Saied K.F.; Eissa I.H.; Elkaeed E.B.; Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine deriva-tives as dual EGFR\/HER2 inhibitors and apoptosis inducers. Bioorg Chem 2019,88,102944","journal-title":"Bioorg Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"Jemal A.","year":"2011","unstructured":"Jemal A.; Bray F.; Center M.M.; Ferlay J.; Ward E.; Forman D.; Global cancer statistics. CA Cancer J Clin 2011,61(2),69-90","journal-title":"CA Cancer J Clin"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1021\/cr900019j","volume":"109","author":"Cragg G.M.","year":"2009","unstructured":"Cragg G.M.; Grothaus P.G.; Newman D.J.; Impact of natural products on developing new anti-cancer agents. Chem Rev 2009,109(7),3012-3043","journal-title":"Chem Rev"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"McCubrey J.A.","year":"2007","unstructured":"McCubrey J.A.; Steelman L.S.; Chappell W.H.; Abrams S.L.; Wong E.W.; Chang F.; Lehmann B.; Terrian D.M.; Milella M.; Tafuri A.; Stivala F.; Libra M.; Basecke J.; Evangelisti C.; Martelli A.M.; Franklin R.A.; Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007,1773(8),1263-1284","journal-title":"Biochim Biophys Acta"},{"key":"ref=39","first-page":"254","volume":"11","author":"Najm M.A.A.","year":"2020","unstructured":"Najm M.A.A.; Oudah K.H.; Hassan W.N.M.; Roomi A.B.; An insight into Pyrazolo scaffold as anticancer. Sys Rev Pharm 2020,11(11),254-263","journal-title":"Sys Rev Pharm"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1568009033481787","volume":"3","author":"Whitesell L.","year":"2003","unstructured":"Whitesell L.; Bagatell R.; Falsey R.; The stress response: Implications for the clinical development of hsp90 inhibitors. Curr Cancer Drug Targets 2003,3(5),349-358","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1016\/j.bmcl.2005.08.091","volume":"15","author":"Brough P.A.","year":"2005","unstructured":"Brough P.A.; Barril X.; Beswick M.; Dymock B.W.; Drysdale M.J.; Wright L.; Grant K.; Massey A.; Surgenor A.; Workman P.; 3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone. Bioorg Med Chem Lett 2005,15(23),5197-5201","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1016\/j.ejmech.2010.09.054","volume":"45","author":"Farag A.M.","year":"2010","unstructured":"Farag A.M.; Ali K.A.; El-Debss T.M.; Mayhoub A.S.; Amr A.G.; Abdel-Hafez N.A.; Abdulla M.M.; Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents. Eur J Med Chem 2010,45(12),5887-5898","journal-title":"Eur J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature03097","volume":"432","author":"Kastan M.B.","year":"2004","unstructured":"Kastan M.B.; Bartek J.; Cell-cycle checkpoints and cancer. Nature 2004,432(7015),316-323","journal-title":"Nature"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nrc1296","volume":"4","author":"Zhou B.B.S.","year":"2004","unstructured":"Zhou B.B.S.; Bartek J.; Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nat Rev Cancer 2004,4(3),216-225","journal-title":"Nat Rev Cancer"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1021\/jm061247v","volume":"50","author":"Tao Z.F.","year":"2007","unstructured":"Tao Z.F.; Li G.; Tong Y.; Stewart K.D.; Chen Z.; Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors. J Med Chem 2007,50(7),1514-1527","journal-title":"J Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1016\/j.bmcl.2010.12.038","volume":"21","author":"Newhouse B.J.","year":"2011","unstructured":"Newhouse B.J.; Hansen J.D.; Grina J.; Welch M.; Topalov G.; Littman N.; Callejo M.; Martinson M.; Galbraith S.; Laird E.R.; Brandhuber B.J.; Vigers G.; Morales T.; Woessner R.; Randolph N.; Lyssikatos J.; Olivero A.; Non-oxime pyrazole based inhibitors of B-Raf kinase. Bioorg Med Chem Lett 2011,21(11),3488-3492","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1016\/j.bmcl.2007.05.041","volume":"17","author":"Nie Z.","year":"2007","unstructured":"Nie Z.; Perretta C.; Erickson P.; Margosiak S.; Almassy R.; Lu J.; Averill A.; Yager K.M.; Chu S.; Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2. Bioorg Med Chem Lett 2007,17(15),4191-4195","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bmcl.2007.11.074","volume":"18","author":"Nie Z.","year":"2008","unstructured":"Nie Z.; Perretta C.; Erickson P.; Margosiak S.; Lu J.; Averill A.; Almassy R.; Chu S.; Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities. Bioorg Med Chem Lett 2008,18(2),619-623","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1016\/j.ejmech.2011.08.014","volume":"46","author":"Balbi A.","year":"2011","unstructured":"Balbi A.; Anzaldi M.; Macci\u00f2 C.; Aiello C.; Mazzei M.; Gangemi R.; Castagnola P.; Miele M.; Rosano C.; Viale M.; Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity. Eur J Med Chem 2011,46(11),5293-5309","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1016\/j.bmc.2010.05.034","volume":"18","author":"Lv P.C.","year":"2010","unstructured":"Lv P.C.; Li H.Q.; Sun J.; Zhou Y.; Zhu H.L.; Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Bioorg Med Chem 2010,18(13),4606-4614","journal-title":"Bioorg Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1016\/j.bmc.2009.09.004","volume":"17","author":"Lian S.","year":"2009","unstructured":"Lian S.; Su H.; Zhao B.X.; Liu W.Y.; Zheng L.W.; Miao J.Y.; Synthesis and discovery of pyrazole-5-carbohydrazide N-glycosides as inducer of autophagy in A549 lung cancer cells. Bioorg Med Chem 2009,17(20),7085-7092","journal-title":"Bioorg Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"10165","DOI":"10.1016\/j.bmc.2008.10.066","volume":"16","author":"Zhang J.H.","year":"2008","unstructured":"Zhang J.H.; Fan C.D.; Zhao B.X.; Shin D.S.; Dong W.L.; Xie Y.S.; Miao J.Y.; Synthesis and preliminary biological evaluation of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives as potential agents against A549 lung cancer cells. Bioorg Med Chem 2008,16(24),10165-10171","journal-title":"Bioorg Med Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.ejmech.2008.01.021","volume":"43","author":"Xia Y.","year":"2008","unstructured":"Xia Y.; Fan C.D.; Zhao B.X.; Zhao J.; Shin D.S.; Miao J.Y.; Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells. Eur J Med Chem 2008,43(11),2347-2353","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ejmech.2009.12.039","volume":"45","author":"Chou L.C.","year":"2010","unstructured":"Chou L.C.; Huang L.J.; Hsu M.H.; Fang M.C.; Yang J.S.; Zhuang S.H.; Lin H.Y.; Lee F.Y.; Teng C.M.; Kuo S.C.; Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3,2-c]pyrazole derivatives as new anticancer agents. Eur J Med Chem 2010,45(4),1395-1402","journal-title":"Eur J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1016\/j.ejmech.2010.07.064","volume":"45","author":"Nitulescu G.M.","year":"2010","unstructured":"Nitulescu G.M.; Draghici C.; Missir A.V.; Synthesis of new pyrazole derivatives and their anticancer evaluation. Eur J Med Chem 2010,45(11),4914-4919","journal-title":"Eur J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1016\/j.bmc.2010.06.046","volume":"18","author":"Bandgar B.P.","year":"2010","unstructured":"Bandgar B.P.; Totre J.V.; Gawande S.S.; Khobragade C.N.; Warangkar S.C.; Kadam P.D.; Synthesis of novel 3,5-diaryl pyrazole deriva-tives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents. Bioorg Med Chem 2010,18(16),6149-6155","journal-title":"Bioorg Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s00044-011-9563-y","volume":"21","author":"Rao R.R.","year":"2012","unstructured":"Rao R.R.; Chaturvedi V.; Babu K.S.; Synthesis and anticancer effects of pongamol derivatives on mitogen signalling and cell cycle kinas-es. Med Chem Res 2012,21,634-641","journal-title":"Med Chem Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.jinorgbio.2011.09.021","volume":"105","author":"Quirante J.","year":"2011","unstructured":"Quirante J.; Ruiz D.; Gonzalez A.; L\u00f3pez C.; Cascante M.; Cort\u00e9s R.; Messeguer R.; Calvis C.; Baldom\u00e0 L.; Pascual A.; Gu\u00e9rardel Y.; Pradines B.; Font-Bard\u00eda M.; Calvet T.; Biot C.; Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: Synthesis, characterization and in vitro activities. J Inorg Biochem 2011,105(12),1720-1728","journal-title":"J Inorg Biochem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejmech.2018.01.082","volume":"149","author":"Kumar G.","year":"2018","unstructured":"Kumar G.; Tanwar O.; Kumar J.; Akhter M.; Sharma S.; Pillai C.R.; Alam M.M.; Zama M.S.; Pyrazole-pyrazoline as promising novel antimalarial agents: A mechanistic study. Eur J Med Chem 2018,149,139-147","journal-title":"Eur J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1016\/j.bmcl.2011.03.037","volume":"21","author":"Aher R.B.","year":"2011","unstructured":"Aher R.B.; Wanare G.; Kawathekar N.; Kumar R.R.; Kaushik N.K.; Sahal D.; Chauhan V.S.; Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors. Bioorg Med Chem Lett 2011,21(10),3034-3036","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1021\/jm201108k","volume":"54","author":"Gonz\u00e1lez Cabrera D.","year":"2011","unstructured":"Gonz\u00e1lez Cabrera D.; Douelle F.; Feng T.S.; Nchinda A.T.; Younis Y.; White K.L.; Wu Q.; Ryan E.; Burrows J.N.; Waterson D.; Witty M.J.; Wittlin S.; Charman S.A.; Chibale K.; Novel orally active antimalarial thiazoles. J Med Chem 2011,54(21),7713-7719","journal-title":"J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1021\/ci100039k","volume":"50","author":"Kortagere S.","year":"2010","unstructured":"Kortagere S.; Welsh W.J.; Morrisey J.M.; Daly T.; Ejigiri I.; Sinnis P.; Vaidya A.B.; Bergman L.W.; Structure-based design of novel small-molecule inhibitors of Plasmodium falciparum. J Chem Inf Model 2010,50(5),840-849","journal-title":"J Chem Inf Model"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1016\/j.bmcl.2010.05.069","volume":"20","author":"Wanare G.","year":"2010","unstructured":"Wanare G.; Aher R.; Kawathekar N.; Ranjan R.; Kaushik N.K.; Sahal D.; Synthesis of novel alpha-pyranochalcones and pyrazoline derivatives as Plasmodium falciparum growth inhibitors. Bioorg Med Chem Lett 2010,20(15),4675-4678","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1016\/j.bmc.2007.12.054","volume":"16","author":"Mishra S.","year":"2008","unstructured":"Mishra S.; Karmodiya K.; Surolia N.; Surolia A.; Synthesis and exploration of novel curcumin analogues as anti-malarial agents. Bioorg Med Chem 2008,16(6),2894-2902","journal-title":"Bioorg Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bmcl.2005.10.033","volume":"16","author":"Cunico W.","year":"2006","unstructured":"Cunico W.; Cechinel C.A.; Bonacorso H.G.; Martins M.A.; Zanatta N.; de Souza M.V.; Freitas I.O.; Soares R.P.; Krettli A.U.; Antima-larial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)-chloroquine analogues. Bioorg Med Chem Lett 2006,16(3),649-653","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/00397910500334561","volume":"36","author":"Kumar S.","year":"2006","unstructured":"Kumar S.; Kumar G.; Kapoor M.; Synthesis and evaluation of substituted pyrazoles: potential antimalarials targeting the Enoyl-ACP reductase of Plasmodium falciparum. Synth Commun 2006,36,215","journal-title":"Synth Commun"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ejmech.2013.04.043","volume":"66","author":"El-Borai M.A.","year":"2013","unstructured":"El-Borai M.A.; Rizk H.F.; Beltagy D.M.; El-Deeb I.Y.; Microwave-assisted synthesis of some new pyrazolopyridines and their antioxi-dant, antitumor and antimicrobial activities. Eur J Med Chem 2013,66,415-422","journal-title":"Eur J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bmcl.2012.11.024","volume":"23","author":"Sharifzadeh B.","year":"2013","unstructured":"Sharifzadeh B.; Mahmoodi N.O.; Mamaghani M.; Tabatabaeian K.; Chirani A.S.; Nikokar I.; Facile regioselective synthesis of novel bioactive thiazolyl-pyrazoline derivatives via a three-component reaction and their antimicrobial activity. Bioorg Med Chem Lett 2013,23(2),548-551","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jfluchem.2014.08.017","volume":"168","author":"Aggarwal R.","year":"2014","unstructured":"Aggarwal R.; Masan E.; Kaushik P.; Synthesis and biological evaluation of 7-trifluoromethylpyrazolo [1, 5-a] pyrimidines as anti-inflammatory and antimicrobial agents. J Fluor Chem 2014,168,16","journal-title":"J Fluor Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"329681","DOI":"10.1155\/2014\/329681","volume":"2014","author":"Kumar R.","year":"2014","unstructured":"Kumar R.; Arora J.; Ruhil S.; Phougat N.; Chhillar A.K.; Prasad A.K.; Synthesis and antimicrobial studies of pyrimidine pyrazole heter-ocycles. Adv Chem 2014,2014,329681","journal-title":"Adv Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ejmech.2015.09.021","volume":"103","author":"Ibrahim H.S.","year":"2015","unstructured":"Ibrahim H.S.; Abou-Seri S.M.; Tanc M.; Elaasser M.M.; Abdel-Aziz H.A.; Supuran C.T.; Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII. Eur J Med Chem 2015,103,583-593","journal-title":"Eur J Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.4067\/S0717-97072020000104746","volume":"65","author":"Aziz H.","year":"2020","unstructured":"Aziz H.; Zahoor A.F.; Ahmad S.; Pyrazole bearing molecules as bioactive scaffolds: A review. J Chil Chem Soc 2020,65(1),4746-4753","journal-title":"J Chil Chem Soc"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/molecules23010134","volume":"23","author":"Karrouchi K.","year":"2018","unstructured":"Karrouchi K.; Radi S.; Ramli Y.; Taoufik J.; Mabkhot Y.N.; Al-Aizari F.A.; Ansar M.; Synthesis and pharmacological activities of pyrazole derivatives: A review. Molecules 2018,23(1),134","journal-title":"Molecules"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3389\/fchem.2019.00917","volume":"7","author":"Saleh N.M.","year":"2020","unstructured":"Saleh N.M.; El-Gazzar M.G.; Aly H.M.; Othman R.A.; Novel anticancer fused pyrazole derivatives as EGFR and VEGFR-2 dual TK inhibitors. Front Chem 2020,7,917","journal-title":"Front Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"113281","DOI":"10.1016\/j.ejmech.2021.113281","volume":"215","author":"Lin T.","year":"2021","unstructured":"Lin T.; Li J.; Liu L.; Li Y.; Jiang H.; Chen K.; Xu P.; Luo C.; Zhou B.; Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors. Eur J Med Chem 2021,215,113281","journal-title":"Eur J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"131937","DOI":"10.1016\/j.molstruc.2021.131937","volume":"1251","author":"Cherukumalli P.K.R.","year":"2021","unstructured":"Cherukumalli P.K.R.; Tadiboina B.R.; Gulipalli K.C.; Bodige S.; Badavath V.N.; Design and synthesis of novel urea derivatives of py-rimidine-pyrazoles as anticancer agents. J Mol Struct 2021,1251,131937","journal-title":"J Mol Struct"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5691982","volume":"2021","author":"Alsayari A.","year":"2021","unstructured":"Alsayari A.; Asiri Y.I.; Muhsinah A.B.; Anticolon cancer properties of pyrazole derivatives acting through xanthine oxidase inhibition. J Oncol 2021,2021,1-5","journal-title":"J Oncol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bioorg.2018.03.002","volume":"78","author":"Akhtar M.J.","year":"2018","unstructured":"Akhtar M.J.; Khan A.A.; Ali Z.; Dewangan R.P.; Rafi M.; Hassan M.Q.; Akhtar M.S.; Siddiqui A.A.; Partap S.; Pasha S.; Yar M.S.; Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. Bioorg Chem 2018,78,158-169","journal-title":"Bioorg Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"103798","DOI":"10.1016\/j.bioorg.2020.103798","volume":"99","year":"2020","unstructured":"O.M.; Daabees, H.M.G.; Badawi, W.A.; AboulWafaa, O.M. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study. Bioorg Chem AboulWafa2020,99,103798","journal-title":"Bioorg Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1021\/cr400270z","volume":"114","author":"Schenone S.","year":"2014","unstructured":"Schenone S.; Radi M.; Musumeci F.; Brullo C.; Botta M.; Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies. Chem Rev 2014,114(14),7189-7238","journal-title":"Chem Rev"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2016.07.034","volume":"123","author":"El-Moghazy S.M.","year":"2016","unstructured":"El-Moghazy S.M.; George R.F.; Osman E.E.A.; Elbatrawy A.A.; Kissova M.; Colombo A.; Crespan E.; Maga G.; Novel pyrazolo[3,4-d]pyrimidines as dual Src-Abl inhibitors active against mutant form of Abl and the leukemia K-562 cell line. Eur J Med Chem 2016,123,1-13","journal-title":"Eur J Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1021\/acs.jmedchem.6b00065","volume":"59","author":"Fraser C.","year":"2016","unstructured":"Fraser C.; Dawson J.C.; Dowling R.; Houston D.R.; Weiss J.T.; Munro A.F.; Muir M.; Harrington L.; Webster S.P.; Frame M.C.; Brunton V.G.; Patton E.E.; Carragher N.O.; Unciti-Broceta A.; Rapid discovery and structure-activity relationships of pyrazolopyrim-idines that potently suppress breast cancer cell growth via SRC kinase inhibition with exceptional selectivity over ABL kinase. J Med Chem 2016,59(10),4697-4710","journal-title":"J Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bioorg.2018.06.017","volume":"80","author":"Gaber A.A.","year":"2018","unstructured":"Gaber A.A.; Bayoumi A.H.; El-Morsy A.M.; Sherbiny F.F.; Mehany A.B.M.; Eissa I.H.; Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers. Bioorg Chem 2018,80,375-395","journal-title":"Bioorg Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/antibiotics10081002","volume":"10","author":"Marinescu M.","year":"2021","unstructured":"Marinescu M.; Synthesis of antimicrobial benzimidazole-pyrazole compounds and their biological activities. Antibiotics (Basel) 2021,10(8),1002","journal-title":"Antibiotics (Basel)"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/molecules25122758","volume":"25","author":"Alnufaie R.","year":"2020","unstructured":"Alnufaie R.; KC, H. R.; Alsup, N.; Whitt, J.; Chambers, S. A.; Gilmore, D.; Alam, M.A. Synthesis and antimicrobial studies of coumarin-substituted pyrazole derivatives as potent anti-staphylococcus aureus agents. Molecules 2020,25,2758","journal-title":"Molecules"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220303150640","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201659\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220303150640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:13:55Z","timestamp":1693160035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201659\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406418666220303150640","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}